|
Attendee Biographical Paragraphs
Mohammed Afifi, M.D., M.Sc.
Substance Abuse and Research Center/ Gaza, Palestine Authority
I have been active the field of public health, research and health information
since 1990, with special interest in drug addiction and youth health. Milestones
include: directing the department of the Health Promotion and Education in the
Palestinian MOH, directing The Regional Alcohol and Drugs Awareness Resources
(RADAR) International Documentation Center in Gaza Sponsored by CSAP-USA, directing
the Substance Abuse Research Center (SARC), developing the Hospital Discharge
Information System for the MOH, carrying the Health Behavior of School-Aged Children
(HBSC) by WHO in Palestine, and recently carrying the "Developing Early
Awareness System for Drugs Abuse among Youth in Palestine (Gaza and the West
Bank), as a joint project sponsored by MERC program of the USAID. Jointly with
Prof. Richard Rawson, and Richard Isralowitz we published an important book entitled "Drug
Problems: Cross Cultural Policy and Program Development" . I have a
number of additional publications.
[Back || Top]
Sherif F. Atallah, MSc, MRCPsych
The Behman Hospital/Cairo, Egypt
Consultant Psychiatrist
Dr. Atallah is a consultant psychiatrist at the Behman
Psychiatrist Hospital in Cairo-Egypt, and clinical tutor for the Royal
College of Psychiatrists, UK. Having obtained his MSc in
Neuropsychiatry in Cairo, he completed postgraduate training in
Oxford, UK, obtaining the MRCPsych and the Board Certification
in Psychiatry from the University of London in 1992. Dr.
Atallah has been working in Egypt since 1993 – both in hospital
work and outpatient clinics. His interests cover the areas of General
Psychiatry, medical treatments of depression, anxiety disorders
and chemical dependence, as well as psychiatric emergencies.
[Back || Top]
Thomas F. Babor, Ph.D., M.P.H.
University of Connecticut Health Center/Connecticut,
USA
Dr. Babor is currently Professor and Chairman, Department
of Community Medicine and Health Care, University of Connecticut
School of Medicine, Farmington, USA. Dr. Babor received his doctoral degree in
social psychology from the University of Arizona. He
spent several years in postdoctoral research training in social
psychiatry at Harvard Medical School, and subsequently served as
head of social science research at McLean Hospital’s Alcohol
and Drug Abuse Research Center in Belmont, Massachusetts. Since
1982, Dr. Babor has worked as a research professor at the University
Of Connecticut School Of Medicine. He has served as
the Scientific Director of the Alcohol Research Center (1992-1994)
and Interim Chair of the Department of Psychiatry (1994-1998). He
was the Principal Investigator of the Coordinating Center of Project
MATCH, as well as several other multi-center clinical trials of
treatment for alcoholism and drug abuse. He is Associate
Editor-in-Chief as well as Regional Editor of the international
journal, Addiction. His research interests include
screening, diagnosis, early intervention, and treatment evaluation,
as well as socio-cultural factors related to alcohol and drug problems. He
is the author or co-author of over 110 articles published in peer
reviewed scientific journals, and has written or edited more than
15 books and monographs.
[Back || Top]
Charles G. Curie, M.A., A.C.S.W.
Substance Abuse and Mental Health Services Administration,
U.S. Department of Health and Human Services/Washington
DC,USA
Administrator, SAMHSA
Charles G. Curie was nominated by President George W. Bush and
confirmed by the U.S. Senate in October 2001 as Administrator
of the Substance Abuse and Mental Health Services Administration
(SAMHSA). As SAMHSA Administrator, Curie reports to Health
and Human Services Secretary Michael O. Leavitt and leads the
$3.4 billion agency responsible for improving the accountability,
capacity and effectiveness of the Nation’s substance
abuse prevention, addictions treatment and mental health services.
Curie has over 25 years of professional experience
in mental health and substance abuse services field. His
core commitment to ensuring that people with addictive and mental
disorders have the opportunity for full participation in American
society has earned him national recognition and acclaim.
Prior to his confirmation as SAMHSA Administrator, Curie was
appointed by then Governor Tom Ridge as Deputy Secretary for
Mental Health and Substance Abuse Services for the Department
of Public Welfare in Pennsylvania. During his tenure, Curie
implemented a nationally recognized mental health and drug and
alcohol Medicaid managed care program and streamlined fractured
service delivery systems. He also established and implemented
a policy to reduce and ultimately eliminate the use of seclusion
and restraint practices in the state hospital system. This
program won the 2000 Innovations in American Government Award
sponsored by Harvard University’s John F. Kennedy School
of Government, the Ford Foundation, and the Council on Excellence
in Government.
Before his service in the Ridge Administration, Curie was the
Director of Risk Management Services for Henry S. Lehr Inc. in
Bethlehem, PA; President/CEO of the Helen H. Stevens Community
Mental Health Center in Carlisle, PA; and Executive Director/CEO
of the Sandusky Valley Center in Tiffin, Ohio. Curie is
a native of Indiana and a graduate of Huntington College. He
holds a Masters Degree from the University of Chicago School
of Social Service Administration and is also certified by the
Academy of Certified Social Workers.
[Back || Top]
Nina Ebner, M.D.
Medical University Vienna/Vienna, Austria
Department of Psychiatry, Assistant Doctor
Dr. Ebner’s addiction research
includes: Drug Research, Department of Psychiatry, Medical University Vienna,
focusing on diversification of maintenance therapy in opioid dependence; drug
dependence during pregnancy/outcome in children of drug addicted mothers; gender
research; AIDS and drug addiction. Dr. Ebner’s project
work includes: ROSE: Management for high risk opiate addicts
in Europe; GENOTYP 2/3 STUDY, a Randomized, multicenter study to
compare the efficacy of pegylated interferon alfa 2a in combination
with two different doses of ribavairin in patients with chronic
hepatitis C and subtype 2/3; and MOTHER: Maternal Opioid Treament:
Human Experimental Research
[Back || Top]
Mehrdad Eftekhar, M.D.
Iran University of Medical Science/Tehran, Iran
Dr. Eftekhar graduated in psychiatry 6 years ago from Iran University of Medical
Sciences (IUMS) and since then he has worked as the academic member of psychiatric
department of IUMS. His areas of interest in psychiatry are addictive behaviors
and sexual medicine. Dr. Eftekhar has accomplished some research on addiction,
including epidemiology of addiction in Iran and opioid detoxification methods.
[Back || Top]
Ahmed EL-Dosoky, MBBCh; MSc;
MRCPsych
The Behman Hospital/ Cairo, Egypt
Consultant Psychiatrist & Managing Director
I completed my basic medical training
at Benha Faculty of Medicine, Zagazig University in Dec 1983. I continued my
post-graduate training at Benha University Hospital for 3 years and awarded MSc
in Neurology & Psychological
Medicine in November 1989. Then worked at Behman Hospital for 2
years until I joined the Charing Cross General Psychiatric Training
Scheme in the UK between the years 1991 & 1996. I was elected
to the Membership of The Royal College of Psychiatrists in November
1995. I am also an Overseas College Tutor. I was involved in many
research projects in the field of drug addiction working with UNODC
(UN Office on Drug & Crime), ANGA (Anti-Narcotic General Administration),
and UCLA (University of California & Los Angeles).
[Back || Top]
Ahmed Elkashef, M.D., DPMCDA
National Institute on Drug Abuse, National Institutes of Health,
USA
Dr. Elkashef is the chief of the clinical trials branch at NIDA's
division of pharmacotherapies and medical consequences of drug
abuse. The branch design, manage and oversee the conduct of all
phases of clinical trials to seek approval of the FDA for medications
treatment for drugs of abuse.
[Back || Top]
Dr. Michael Farrell
National Addiction Centre/London, United Kingdom
Dr. Farrell is a Reader in Addiction Psychiatry and Consultant Psychiatrist at
the National Addiction Centre and Institute of Psychiatry, Kings College London.
He is responsible for a large community drug and alcohol service. He has extensive
research interests in the social and epidemiological aspects of addictions with
a particular interest in substance use and psychiatric co-morbidity. He has co-edited
the Concise Oxford Texbook of Medicine Section on Addictions. He is also the
Director of Postgraduate Medical Education for the South London and Maudsely
Trust and is responsible for one of the largest postgraduate training programmes
in psychiatry in the UK, with over 400 full time trainees. He is a co-founder
and editor of the Cochrane Collaboration Drug and Alcohol Group. He is an assistant
editor of the journal Addiction. He is a member of Expert Committee on Drug Dependence
at WHO and has worked on numerous international projects with the UN, WHO, European
Commission and the European Monitoring Centre on Drugs and Drug Abuse. He has
published over 200 original articles on various aspects of addictions.
[Back || Top]
Gabriele Fischer, M.D.
Medical University Vienna, Austria
Associate Professor of Psychiatry
Medical Director of Addiction Clinic, Medical University of Vienna
Member of the scientific board for quality control & quality management in
medicine
Board Member of trustees Medical University Innsbruck
Founding (board) member: “Women for women: health policy in focus“
Specialist in Psychiatry and Neurology since 1990.
Dr. Fisher’s Addiction research includes: Director of Addiction clinic,
with research focusing on: diversification of maintenance therapy in opioid dependence; Pregnancy/children
and drug misuse; AIDS and drug addiction; Transcultural and interdisciplinary
studies; gender-research. Dr. Fischer’s International activities
include: Consultant: Council of Europe & WHO; national & international
research cooperation; national & international grant support; Board
member in international organizations: CPDD, ISAM; assistent editor of Top-research
journals.
[Back || Top]
Prof. Tarek A. Gawad
International Society of Addiction Medicine/Cairo University,
Egypt
I am currently holding positions as a Professor of Psychiatry, Cairo University,
Cairo Egypt which is one of the oldest and most prestigious universities in Africa
and the Middle East, as well as serving internationally as the President of the
International Society of Addiction Medicine (ISAM), the Secretary of the World
Psychiatric Association Section of Addiction Psychiatry (WPA) and Temporary Advisor
for the Mediterranean Region of the World Health Organization (EMRO).
I completed my studies in both Cairo (Master & MD Psychiatry) and London
(Diploma in Addiction Behaviour - Institute of Psychiatry) Universities and have
continued involvement in England and Saudi Arabia.
I have participated in advancing of the field of Addiction Medicine by having
an active role in the organization of regional, national and international conferences
of the calibre of the World Psychiatric Association and as well as in the development
of an International Curriculum for Addiction Psychiatry which has been modified
and adapted to the needs of the University of Cairo. Presently he is pivotal
in the Egyptian field in his role as Acting Director and Supervisor of the new
Psychiatric & Drug Addiction Hospital, a 140-bed facility serving six Subspecialties
(Adult, Child & Adolescent, geriatric, Addiction, Liaison & Integrated
Psychiatry). My role as WHO EMRO temporary advisor for the Regional Advisory
Panel on Impact of Drug Abuse (RAPID) for the last two years had resulted the
release of the third report just very recently. I am also participating in the
UNODC / WHO-EMRO research proposal for the pharmaco-epidemiological study on
the use and misuse of prescription psychotropic substances in Greater Cairo.
Last year I was elected as the President of the International Society of Addiction
Medicine (ISAM) for which I am currently acting as the President for 3 year turn
to be renewed.
My goal is to achieve a well-established scientifically-based centre in Drug
Addiction with a suitable network both nationally and internationally.
[Back || Top]
Christine E. Grella, Ph.D.
University of California, Los Angeles-Integrated
Substance Abuse Programs/USA
Dr. Grella is a Research Psychologist at UCLA Integrated Substance
Abuse Programs. Her research focuses on the intersection of multiple service
delivery systems, including substance abuse treatment, mental health, child welfare,
health services, and criminal justice, and the relationship of service delivery
to treatment outcomes. She has published her work widely in the areas of
addiction, mental health, health services, and evaluation research. She
is currently Principal Investigator on a NIDA-funded study, “Gender Differences
in a Long-Term Follow-up of Opiate Users in California”; on the evaluation
of the “Female Offender Treatment and Employment Program,” funded
by the California Department of Corrections and Rehabilitation; on a study entitled, “Linking
Substance Abuse Treatment and Child Welfare Outcomes,” funded by the Robert
Wood Johnson Foundation Substance Abuse Policy Research Program, and on CSAT-funded
evaluations of enhanced treatment interventions for adolescents and for homeless
individuals with co-occurring disorders.
[Back || Top]
Ramzi Haddad, M.D.
Skoun-Lebanese Addiction Center/Beirut, Lebanon
Department of Psychiatry, Rizk Hospital, Beirut, LEBANON
Founding member of SKOUN, Lebanese Center for addictions, the only outpatient
center in Lebanon specialized in the treatment of addictions and covering also
other fields related to addictions such as prevention, social reintegration,
information and research.
[Back || Top]
Albert L. Hasson, M.S.W.
University of California, Los Angeles-Integrated
Substance Abuse Programs/USA
Investigator – UCLA ISAP
Albert L. Hasson, M.S.W., has worked in the field of chemical dependency research
and treatment since 1977. He began his career as a research associate at the
Sepulveda Veterans Administration Medical Center, Drug Dependence Treatment Center
implementing research protocols in the use of naltrexone and levo-alpha-acetylmethadol
(LAAM) for the treatment of narcotic addiction. After leaving the Veterans Administration,
Mr. Hasson worked as a clinic director for Community Health Projects (CHP), Inc.,
the largest provider of narcotic treatment in California. During his seven years
with CHP, Inc., Mr. Hasson facilitated the establishment of several narcotic
treatment programs within San Luis Obispo and Fresno counties. From 1989 until
June 2003, Mr. Hasson worked for the Matrix Institute on Addictions, where he
established several outpatient drug free programs and the Matrix Institute narcotic
treatment program in Los Angeles. Currently, Mr. Hasson works at the UCLA Integrated
Substance Abuse Programs as coordinator for the Pacific Region Node of the National
Institute on Drug Abuse, Clinical Trials Network.
[Back || Top]
Keith Humphreys, Ph.D.
Stanford University/California, USA
Dr. Humphreys is Associate Professor of Psychiatry at Stanford University School
of Medicine and Director, Veterans Affairs Program Evaluation and Resource Center,
which studies treatments and self-help programs for substance abuse and psychiatric
disorders. In addition to his scientific projects, he is actively involved
in teaching addiction treatment methods to medical students, psychiatric residents,
and clinical psychology interns. For the past year, Professor Humphreys
has been working closely with the Iraqi Ministry of Health, the U.S. Substance
Abuse and Mental Health Services Administration and the U.K. West Kent National
Health Service and Social Care Trust on the restoration of the Iraqi psychiatric
and addictive disorder treatment system.
[Back || Top]
Richard Isralowitz, Ph.D.
Ben Gurion University/Be'er-Sheva, Israel
Richard Isralowitz
is professor and director of the Regional Alcohol and Drug Abuse
Resources Center, Ben Gurion University, Israel. He is an advisor to the Israel Center
for International Cooperation and co- chair of the Netherlands/Israel
Research Program for research development in the Middle East
and Africa. He is co-principal investigator with US,
Palestinian and Egyptian colleagues for the development of
an early warning system of high risk youth substance use and
problem behavior as well as adaptation of the Addiction Severity
Index in the Middle East supported by the USAID – Middle
East Regional Cooperation Program. His has published
over 100 articles and 9 books on substance abuse and related
issues. The honors he has received for his work include
Distinguished International Scientist, US National Institute
on Drug Abuse; International University Professor, New York
University; Hallsworth Scholar of Social Policy, University
of Manchester, England; and Fulbright Fellow, University of
Singapore. He received his doctorate from the Florence
Heller Graduate School for Advanced Studies in Social Policy
and Management, Brandeis University.
[Back || Top]
Andrej Kastelic, M.D.
Centre for Treatment of Drug Addiction/ Ljubljana,
Slovenia
Director of National Center for Treatment of Drug Addiction
- Responsible for the treatment programs for Drug Addiction at
Ministry of Health and Ministry of Justice (prison programs)
in Slovenia;
- Founder and Director of the Board of the Sound of Reflection
Foundation;
- Technical adviser of IHRD-OSI for HR and substitution treatment
programs;
- Member of the substitution treatment working groups at WHO,
UNAIDS, UNDCP;
- Consultant of UNAIDS and Imperial Colleague (London): Development
of Research Capacity and Intervention
Models in CEE, SEE and Central Asia;
- President of the SEE Adriatic Addiction Treatment Network;
- Teacher at the Faculty for Social Work, University of
Ljubljana ;
- Member of Expert Committee that had prepared and reviewed EU
Methadone Guidelines;
- Participated in more than 200 international conferences, written
more than 300 books and articles on drug addiction
and had about 900 lectures on the same subject.
- Organiser of International conferences on drug addiction, including
IHRA HR Conference, EUROPAD, SEEA, ISAM
and WHO Symposiums, Vanguard…
- Dole – Nyswander “Marie” Award in 2001 by
AAOTD and several national awards.
[Back || Top]
Dr. Riaz Khan
Geneva University/Geneva, Switzerland
Dr. Khan is currently working in the division of Substance Abuse Department of
Psychiatry, University Hospital, Geneva, Switzerland. He has in the past
managed the Divison of Substance Abuse on two occasions as the interim head and
at present he is working in the capacity of deputy head with Dr Daniele Zullino
as the new head of the Divison of Substance Abuse. Previously he has worked
extensively in the fields of psychogeriatrics and adult psychiatry.
[Back || Top]
Fred Kigozi, M.D.,
M.Med (Psych).
Butabika Hospital/Kampala, Uganda
Medical Director, Butabika Hospital
Senior Consultant Psychiatrist and National Mental Health Policy Advisor, Ministry
of Health, Uganda.
Education: M.Med (Psych), Makerere University. Completed Psychiatric Education
at the Institute of Psychiatry – Maudsley and Royal Liverpool University. Certificates: Health
Services Management - University of California Los Angeles, Anderson School
of Management, USA, and Royal Institute of Public Administration UK.
Involved in several national research projects ie.:
- Role of Alcohol/Substance use in HIV transmission.
- Street children and substance use in Uganda
- Psychiatric epidemiology
- Admission Trends in Uganda psychiatric facilities
- Integration of mental health into general health care.
- Post-traumatic Stress Disorder (PTSD)
Head of National team on an International Multicentre Policy Development Project.
Professional Associations: President Uganda Psychiatric Association, Founder
Member of the African Association of Psychiatrists and Allied Professionals (AAPAP),
World Psychiatric Association (WPA) Zone 14 Representative for Eastern and Southern
Africa, International Advisory Board of several International Congresses, Member
of several scientific committees for both local and International Congresses,
Member of several Juries., Member of Editorial Boards - three Peer Review
International Journals.
[Back || Top]
Levent Küey, M.D.
World Psychiatric Association Southern Europe Zonal Representative/
Istanbul,
Turkey
Associate Professor of Psychiatry
Psychiatry Department of Beyoglu
Training Hospital,
Psychology Department of Istanbul Bilgi University
World Psychiatric Association Board Member & Zonal Representative
for Southern Europe
Professor Küey’s work, research and
teaching experiences extend over 23 years in different psychiatric institutional
settings, as in Mental Health Dispensary (Ankara), Mental Health Hospital (Adana),
Psychiatry Clinic in a General Training Hospital (Izmir) and Psychiatry (Izmir)
and Psychology Departments (Istanbul Bilgi) in University. He is the
author of over 50 scientific journal articles, specially on depressive and
anxiety disorders, psychiatric epidemiology, patient formulation, social and
cultural psychiatry, psychopathology and author of book chapters (including
Psychiatric Epidemiology in the Essentials of Psychiatry, main text book in
Turkish). Professor Küey’smain research areas involve social psychiatry,
psychiatric epidemiology, phenomenology of depressive and anxiety disorders,
psychometric instruments, classification and diagnostic systems (as, assessing
the validity and reliability of Hospital Anxiety Depression Scale and of Edinburgh
Post-Natal Depression Scale; Clinical Pattern of Depressive Disorders in Turkey-a
multi-centered research on over 2000 patients; epidemiology of and attitudes
towards affective disorders- a field survey. Current research includes Education-Treatment-Follow
up of Depressive Disorders (Research Project undertaken by Turkish Branch of
the Asian Union against Depression, in accordance with South Asian countries);
The use of artistic creativity in teaching psychopathology; General Psychopathology;
International Classification and Diagnostic Systems, Mental Health Programs
in developing countries. His other professional activities include:Editor of
the Turkish Archives of Neuropsychiatry, and member of the scientific board
of the four leading journals of psychiatry in Turkey. Member in the International
Scientific Board of “Investigacion en Salud” (official publication
of the Centro Universitario de Ciencias de la Salud de la Universidad de Guadalajara,
Mexico), Founder member and Executive Committee member of the Psychiatric Association
of Turkey. Member of the Turkish Neuropsychiatric Association, of the Turkish
Association of Social Psychiatry, and of the Turkish Association of Psychodrama
Group Psychotherapy. General Secretary of the Psychiatric Association of Izmir
(1992-1999). Member of the Honorary Board of the Izmir Chamber of the Turkish
Medical Association (1992-1994). Chair of the Section on Psychiatric Epidemiology
of the Psychiatric Association of Turkey. Member of the WHO working group on
the implementation of a National Mental Health Plan for Turkey (1986-1989).
Member of the WPA Section on Classification, Diagnostic Assessment and Nomenclature.
Member of the working group of WPA Educational Program on International Guidelines
for Diagnostic Assessment (IGDA). Member of the WPA Task Force on Globalization
and Mental Health. Member of the work group of International Classification
and Diagnostic Systems to develop World Health Organization-International Classification
of Diseases - 11.
Professor Küey received the Research award of the Turkish
Journal of Psychiatry, in 1997, for the studies on the distinctive
and overlapping features of depressive and anxiety disorders.
[Back || Top]
Walter Ling, M.D.
University of California, Los Angeles-Integrated
Substance Abuse Programs/USA
Director, UCLA ISAP
Dr. Walter Ling is a Professor of Psychiatry and the Director
of the Integrated Substance Abuse Programs (ISAP) at UCLA, one
of the foremost substance abuse research groups in the U.S. and
worldwide. Dr. Ling is board certified in neurology and psychiatry
and is active in both research and clinical work, having been listed
in the “Best Doctors in America,” “Best Doctors
in the West” and “Best Doctors in Los Angeles.” Dr.
Ling’s work in opiate pharmacotherapy has provided pivotal
information for the approval of LAAM, naltrexone, and buprenorphine. The
scope of ISAP’s research has ranged from evaluation of medications
and development of psychosocial strategies for the treatment of
opiate, cocaine, methamphetamine, alcohol, and nicotine abuse and
dependence to a wide range of epidemiological and treatment service
outcome research in California and throughout the U.S. ISAP
is currently involved in several major collaborative efforts internationally
in developing effective treatment strategies for methamphetamine
and opiate abuse and dependence in Thailand, the Middle East, Mexico
and Africa.
[Back || Top]
Mansour Mabrouk Shawky
Assiut University Hospital/Assiut, Egypt
Assistant lecturer of psychiatry, Assiut University, Egypt
I have worked in Assiut University Hospital since 2000, and I am interested
in the field of substance use disorders. Now I am taking a training on management
of addiction in Ain Shams Psychiatry Institute, Egypt. After that I
will go to UCLA to get more advanced training on management of addiction.
[Back || Top]
Selin Müderrisoglu Hatipoglu,
MA
İstanbul Bilgi University/Istanbul, Turkey
Undergraduate degree in Psychological Counseling and Chemistry
Master’s degree in Forensic Sciences (Forensic Psychology)
Doctorate degree in Forensic Sciences ( Forensic Psychology – in dissertation
stage)
I have been working at the Psychology Department of İstanbul Bilgi University
since 1999 as a teaching assistant. My major interest area of research is substance
use and prevention. I am the founder and supervisor of “NODO Substance
Abuse Prevention Club” which is established at İstanbul Bilgi University
as a student club. We, as NODO, have been working on substance abuse prevention
in young population. We do research, attend to trainings and congresses both
nationally and internationally as an active club. And this year I am honored
to be selected as an Expert Advisor for Pompidou Group - Council of Europe’s
2006 Prevention Prize Jury.
[Back || Top]
Professor R. Srinivasa Murthy
World Health Organization/Regional Office for the Eastern
Mediterranean/
Cairo, Egypt
Dr. Murthy is working (since September 2003) with the Eastern Mediterranean Regional
Office of the World Health Organisation with the Mental Health Unit at Cairo,
Egypt. The work of the Regional office covers 22 countries from Afghanistan to
Morocco, with over 500 million population. During the last two years, Dr.Murthy
has been involved in developing and collecting the information about the drug
abuse situation in the member countries as well as developing prevention programmes.
One of the important outcomes is the development of Regional Life Skills Education
manual and substance education materials in Arabic language. A Regional strategy
for drug abuse has been developed.
He was the Chief Editor of the World Health Report 2001(Mental Health) of the
World Health Organisation.
He was earlier Professor of Psychiatry at the National Institute of Mental Health
and Neurosciences, Bangalore, India (1986-2003). He has over 200 scientific publications, including
more than a dozen manuals on mental health for non-psychiatrists.
[Back || Top]
Professor David M. Ndetei
University of Nairobi/Kenya, Nairobi
Professor Ndetei is the Chair of Psychiatry, University of Nairobi, Kenya. He
also founded the Africa Mental health Foundation, Dedicated to Research for evidence-based
Policy, Practice in and Promotion of Mental and Neurological Health and Healthy
Behavior. He has researched on substance use and abuse in Kenyan Secondary
Schools, General Hospitals, Mental facilities and in the communities. He
has also supervised several degree dissertations in substance abuse. His
recent researches have focused on the IDUs/HIV/AIDS, and recent trends on sexual
behaviour in Kenyan youth in relations to HIV/AIDS. He has also studied
the bio-psycho-social model in substance abuse, especially in causation, co-morbidity
and management. He has just finished compiling materials for a Monograph
on Recent trends on substance use and abuse in Kenya. E-mail: dmndetei@mentalhealthafrica.com
[Back || Top]
Professor Akwasi Osei
Accra Psychiatric Hospital/Accra, Ghana
Dr. Osei is a 47-year
old Ghanaian, currently the Director of Accra Psychiatric Hospital
which is the first and the largest of the three psychiatric hospitals
in Ghana, and the Acting Chief Psychiatrist of the Ghana Health
Service. He is a Fellow of the West African College of Physicians
and a foundation Fellow of the Ghana College of Physicians and
Surgeons, in the Faculty of Psychiatry. Also a Hubert H. Humphrey
Fellow in Substance Abuse from Johns Hopkins University at Maryland,
Baltimore, from 1995 to 1996. He is a member of the Narcotics Control
Board of Ghana. Akwasi Osei had his basic medical training from
the Kwame Nkrumah University of Science and Technology School of
Medical Sciences, Kumasi, Ghana. His wide interests in mental health
include ethnopsychiatry and herbal teatment of drug and alcohol
abuse. He is currently collaborating with some herbal practitioners
to research into the efficay of herbal treatment of substance abuse. Akwasi
Osei is married with two children and a Baha'I by religion.
[Back || Top]
Valerie Pearce, B.A.
University of California, Los Angeles-Integrated
Substance Abuse Programs/USA
Project Director, UCLA ISAP
Valerie Pearce is currently a project director at UCLA Integrated Substance Abuse
Programs (UCLA-ISAP). For the last five years, she has coordinated and managed
the NIDA funded Methamphetamine Clinical Trials Group (MCTG), a multi-site methamphetamine
medication-testing network. This network was initiated by NIDA not only to investigate
multiple protocols in various methamphetamine populations nationally, but also
to contribute to the initiative of blending research and treatment philosophies. In
addition, Ms. Pearce has organized and administered multiple trainings and conferences
for UCLA-ISAP. She has developed monitoring strategies, and continues to oversee
regulatory requirements, implement budget and contract guidelines, and supervise
day-to-day clinic activities in order to execute multiple and simultaneous research
treatment designs. Ms Pearce began her career at the Matrix Institute on
Addiction, a non-profit organization which has been established to provide research,
training, and public sector treatment on substance abuse disorders. There she
has worked on private and federally funded grants executing trials treating alcohol,
cocaine, methamphetamine, opiate, and marijuana additions. She has gained valuable
experience in a wide variety of substance use disorders.
[Back || Top]
Vladimir B. Poznyak, M.D., Ph.D.
World Health Organization/Geneva, Switzerland
Department of Mental Health and Substance Abuse
Management of Substance Abuse
Vladimir B. Poznyak is a Coordinator of the Management of Substance Abuse unit
at the Department of Mental Health and Substance Abuse of the World Health Organization
(WHO). Before joining the WHO Department of Mental Health and Substance Abuse
in Geneva in 2000, Dr V. Poznyak had an experience of working on alcohol and
drugs at the WHO Regional Office for Europe (Copenhagen, Denmark). His current
responsibilities in WHO include normative, advocacy, research and country support
activities related to alcohol and drugs.
Dr Poznyak received his M.D. degree and postgraduate training in psychiatry at
the Belarussian State Medical University (Belarus), and Ph.D. from the
All-Union Research Institute of Medical and Biological Problems of Addictions
in Moscow (Russian Federation). Before joining WHO Dr Poznyak served as an Associate
Professor at the Department of Psychiatry and Medical Psychology and a Head of
Social and Clinical Psychiatry Research Unit in Belarussian State Medical University.
[Back || Top]
Prof Solomon T. Rataemane, MBCHB, Dipl. Child Psychiatry, FFPsych
(SA)
University of Limpopo/Pretoria, South Africa
Head Department of Psychiatry, University of Limpopo (MEDUNSA)
Acting Chair, Central Drug Authority of South Africa
Medicines Control Council (Scheduling and Clinical Trials Committees)
Senator for Psychiatry- Colleges of Medicine of South Africa (CMSA)
Member, Medical and Dental Professions Board
Appointed Chairperson of the Central Drug Authority of South Africa
Appointed Assistant Dean (Clinical Affairs) Medunsa Campus, University
of Limpopo
Awards and Honours:
- Honoured by UNICOC (Tvl. Chamber of Commerce) for community involvement and
Health advocacy in the context of Human rights.
- Travel sponsorship to participate in the American Public Health Association
annual meeting – to address the topic of “the impact of violence
on children”.
- Nominated, reached the final short list for the NELSON MANDELA AWARD FOR HEALTH
AND HUMAN RIGHTS.
- Received “The Global Partner Award” from the Dr. Lonnie E Mitchell
National HBCU Substance Abuse Conference in Baltimore, Maryland, USA for “Excellence
in the Pursuit of Global Collaboration and Cooperation in Substance Abuse Research,
Treatment, Prevention,Education and Policy”.
[Back || Top]
Richard A. Rawson, Ph.D.
University of California, Los Angeles-Integrated
Substance Abuse Programs/USA
Associate Director, UCLA ISAP
Richard Rawson received a Ph.D. in experimental psychology from the University
of Vermont in 1974. Since that time he has spent his career conducting research
and developing treatment systems for substance abuse disorders. Dr. Rawson has
been a member of the UCLA Department of Psychiatry for over 20 years and is currently
the associate director of the UCLA Integrated Substance Abuse Programs. In this
role, Dr. Rawson oversees a portfolio of addiction research ranging from brain
imaging studies to numerous clinical trials on pharmacological and psychosocial
addiction treatments, to the study of how new treatments are applied in the treatment
system. During the past decade, he has worked with the US State Department on
large substance abuse research and treatment projects, exporting US technology
and addiction science to Mexico, Thailand, Israel, Egypt and the Palestinian
Authority. Dr. Rawson has published 2 books, 15 book chapters and over 125 professional
papers and has conducted over 1000 workshops, paper presentations and training
sessions. He is a hopeless Boston Red Sox fan.
[Back || Top]
Paul Restovich
University of California, Los Angeles-Integrated
Substance Abuse Programs/USA
Principal Administrative Analyst, UCLA ISAP
Mr. Restovich has had over 15 years experience in financial management of contracts
and grants at UCLA. He oversees the fiscal management of the Center. He serves
as liaison with federal, state, and local granting agencies, as well as campus
administrative departments and other affiliated organizations, to facilitate
successful functioning of fiscal operations. Mr. Restovich will work with ISAP
PIs and other project personnel to maintain budget reporting and monitoring procedures
required by UCLA and funding agencies. He is familiar with university reporting
requirements and his experience in these areas will ensure up-to-date monitoring
and compliance with all relevant Federal and State regulations.
[Back || Top]
Francisco Javier Romero, M.D., Ph.D.
University Cardenal Herrera-CEU/Valencia, Spain
Francisco Javier Romero is Professor of Physiology at the Department of Physiology,
Pharmacology and Toxicology of the Universidad Cardenal Herrera-CEU in Valencia,
Spain. Post-doc experience at USC (Los Angeles, CA), Karolinska Institute (Sweden),
Alexander von Humboldt fellow in Germany. Since 2003 Director of the Instituto
de Drogas y Conductas Adictivas (IDYCA) whic is a university research institute
devoted to drug abuse and addictive behaviours. Personal research interests are
related to deletereous effects of ethanol in nervous tissue (biochemical changes,
signalling within neurons, neurogenesis, neuroprotection). More recently the
group has started studies in human addicts to cocaine with neuroimaging.
The IDYCA is directly related to the regional authorities and is interested in
developing some epidemiological studies mainly related to HIV and addiction in
different populations.
[Back || Top]
Robert Schilling, Ph.D.
University of California, Los Angeles-School
of Public Affairs/USA
Dr. Schilling received his M.S.W. from the University of Wisconsin-Madison,
and his doctorate in social welfare from the University of Washington. He practiced
for many years in child welfare, youth, and developmental disability settings.
Formerly, he was a professor at Columbia University School of Social Work, where
he co-founded and directed the Social Intervention Group. At UCLA, he is Professor
of Social Welfare at the School of Public Policy and Social Research, and a member
of the CHIPTS and the AIDS Institute. In his research, Professor Schilling seeks
to develop, adapt, and test sociobehavioral interventions designed to ameliorate
social and health problems of low income populations in the U.S. and the developing
world. The bulk of his research is focused on substance abuse and related problems
including HIV transmission and family violence. Dr. Schilling's studies have
been conducted in sites as disparate a small soup kitchen, street outreach programs,
sexually transmitted disease clinics, emergency departments, and primary care,
detoxification and methadone clinics. Dr. Schilling has published over 130 publications,
including articles in Social Work, Science, The New England Journal of Medicine,
The Journal of the American Medical Association, The American Journal of Public
Health, and The American Psychologist.
[Back || Top]
Lieutenant Commander Todd Stankewicz
Deputy Health Attaché/Baghdad, Iraq
Lieutenant Commander Todd Stankewicz is a Commissioned Officer with the US Public
Health Service. He is currently assigned to the US Embassy in Baghdad as
the Deputy Health Attaché. Mr. Stankewicz graduated from Drake University
with a Bachelor in Pharmacy degree. He began his career as a pharmacy resident
at Mayo Medical Center. After Mayo he worked in several facets in the field of
pharmacy including: industry, community and mail order. In 1991 he earned
duel masters degrees in both public health and business administration. Before
taking the assignment in Iraq he has been working for the FDA in Chicago, concentrating
on drug importation as well as drug inspections and investigations.
[Back || Top]
Jack B. Stein, Ph.D.
National Institute on Drug Abuse, National Institutes of Health,
USA
Dr. Jack B. Stein is Deputy Director for the Division of Epidemiology,
Services, and Prevention Research of the National Institute on
Drug Abuse (NIDA), a part of the National Institutes of Health
(NIH). Previous positions held at NIDA include Chief, Services
Research Branch and Deputy Director, Office of Science Policy
and Communications. A clinical social worker by training, Dr.
Stein has extensive experience in prevention, treatment, and
policy issues related to drug abuse and HIV/AIDS service delivery
with a particular interest in the translation and application
of research-based findings to real world settings. Before entering
government, Dr. Stein was the Executive Director of the Health
Education and Resource Organization, Maryland's largest AIDS
service organization. He has developed numerous curricula for
health care professionals and has conducted training and technical
assistance on a community, national, and federal level on various
issues related to drug abuse and HIV prevention. Dr. Stein has
published in the Journal of Social Work Practice in the Addictions
and co-edited an issue of the Journal of Substance Abuse Treatment
on blending research and clinical practice.
[Back || Top]
Kerstin Stenius, Ph.D.
Nordic Studies on Alcohol and Drugs (NAT)/Helsinki
Finland & Stockholm, Sweden
Professor
Stenius is a researcher for the Centre for Social Research on Alcohol
and Drugs, Stockholm University, Sweden; senior lecturer, Department
of Social Policy, Helsinki University, Finland; editor-in-chief,
Nordic Studies of Alcohol and Drugs, National Research and Development
Centre for Welfare and Health (Stakes), Finland. Earlier research
on immigration and mental health, since the 1980s mainly on
treatment systems for alcohol and drug abusers (treatment’s
relation to AA and other social movements, diffusion of treatment
methods and ideologies, privatisation and new public management
in addiction treatment, effects of different organisational
models) and on the (Nordic) history of social control of substance
abusers. Past president (2002-2004) of International Society
for Addiction Journal Editors (ISAJE), now chair of ISAJEs
language issue group.
[Back || Top]
Juana M. Tomás Rosselló, M.D., M.P.H.,
Drug Abuse Treatment Adviser, UNODC
United Nations Office on Drugs and Crime/Vienna, Austria
Drug Abuse Treatment Adviser, UNODC
Juana Tomás has more than 20 years of experience in drug demand reduction,
particularly in the areas of drug abuse treatment and epidemiology. She
combined her initial clinical work at a drug dependence treatment centre in Barcelona
with further studies on Public Health at Johns Hopkins University. During
her stay as a Visiting Scientist at the National Institute on Drug Abuse (NIDA),
she conducted field studies and epidemiological investigations, and designed
epidemiological studies. Between 1990 and 1999 she worked in different
capacities for the European Commission, the European Monitoring Centre on Drugs
and Drug Addiction (EMCDDA), and the United Nations International Drug Control
Programme (UNDCP). In her current role Dr. Tomás provides technical support
and advice to UNODC programmes and Member States and is responsible for the synthesis
and dissemination of best practices and lessons learned on drug abuse treatment
and rehabilitation. She coordinated the development of a "Drug Abuse
Treatment Toolkit" and is responsible for an International Network of Resource
Centres on Treatment and Rehabilitation.
[Back || Top]
Jallal Toufiq, M.D.
Hospital Ar-razi/ Sale, Morocco
Director of the Ar-razi University Psychiatric Hospital, Salé, Morocco.
Head of the National Center on Drug Abuse Prevention and Research
Professor of Psychiatry: Rabat Faculty of Medicine.
Advisor to the Minister of Health on Mental Health and Drug Abuse issues
In charge of in- and outpatient programs at Ar-razi University Psychiatric Hospital:
adult and child psychiatry
Coordinator of the teaching and residency training activities at the
Ar-razi hospital and the Rabat Faculty of Medicine.
Supervisor of the National Diploma on Treatment and Prevention of Drug Abuse
at the Rabat Faculty of Medicine
Expert for the Pompidou Group (Council of Europe) on drug abuse prevention and
research
Focal point / expert on Prevention for the UN Office on Drug Control and Crime
Prevention (Local Network for North Africa);
Former resource person for the International Council on Alcoholism and Addictions.
Dr. Toufiq’s special skills
include the following: Broad knowledge in epidemiology and biostatistics
applied to drug abuse and mental health, Good expertise
in the field of drug abuse prevention policy in developing countries,
Trained in the Addiction Severity Index, UMBC, Trained in the
Drug Clinical Trial Methodology (advanced course), Vienna School
of Clinical Research.
Dr. Toufiq’s Non-Governmental Organizational
memberships include: Past Secretary General of the Moroccan Psychiatric Society (Salé,
Morocco), Member of the Rabat-Salé League for Mental Health (Salé,
Morocco), Board member of the Moroccan Society of Biological Psychiatry (Salé,
Morocco), Member of the Moroccan Society of Medical Sciences (Rabat, Morocco),
Member of Albadil: Moroccan Association for Drug Abuse Prevention (Rabat),
Founderof the Arab Association for Prevention of Drug Abuse (Cairo), Founder of
the Arab Federation of NGOs for Drug Abuse Prevention (Cairo), Founder and
past president of SOS-SIDA, a Moroccan NGO on AIDS and Drug Abuse Prevention
in Youth (Rabat, Morocco).
[Back || Top]
Ambros A. Uchtenhagen, M.D., Ph.D.
Addiction Research Institute/Zurich, Switzerland
Em. Professor of Social Psychiatry at Zurich University
Research Foundation for Public Health and Addiction at Zurich University (Chairman
of the Board)
Main interests in the field : epidemiology of addictive behaviour, implementation
and evaluation of preventive and therapeutic interventions, drug policy.
Co-editor-in chief of European Addiction Research, Karger publishers Basel
First author of over 250 publications, Editor of a handbook on Addiction Medicine
(Urban & Fischer publishers, Munich).
Numerous missions and research projects for WHO, European Union, Council of Europe.
Member of WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems.
[Back || Top]
Darren Urada, Ph.D.
University of California, Los Angeles-Integrated
Substance Abuse Programs/USA
Project Director & Investigator – UCLA ISAP
Dr. Urada is a Project Director at the UCLA Integrated Substance Abuse Programs,
and is Co-Principal Investigator of this conference. Prior to his work in the
field of Substance Abuse, Dr. Urada’s area of specialization was inter-group
relations and he is therefore very happy to see attendees from so many different
nations together at this conference to discuss shared problems and solutions
related to substance abuse. In addition to this conference he is working
on the state of California’s evaluation of the Substance Abuse and Crime
Prevention Act of 2000, which places non-violent substance abusers into treatment
rather than into jail or prison. In addition, he is in charge of external
communications for UCLA ISAP. Previously Dr. Urada was the project director
for the California State Treatment Needs Assessment Program, served as project
director for a study on substance abuse and welfare reform, and worked on the
California Treatment Outcome Project (CalTOP), meta-analytic studies on substance
abuse and HIV/AIDS, and research on treatment expansion. He has also spent time
as a volunteer relapse prevention group facilitator at the Matrix Institute on
Addictions. He has worked for the UCLA Integrated Substance Abuse Programs since
1998.
[Back || Top]
Anatoliy M.Viyevskyy, M.D., Ph.D.
Ministry
of Health/Kiev, Ukraine
Head Narcologist of The Ministry of Health of Ukraine
Head of The All-Ukrainian Narcological Association
Director of The Kyiv City Narcological Clinic “Sociotherapy”,
Consultant in alcohol/drug prevention, ILO, Geneva, Switzerland
Temporary Advisor in alcohol policy,WHO, Copenhagen, Denmark
Director of The Ukrainian Scientific and Clinical Rehabilitation Center on Chemical
Dependencies, Ministry of Health of Ukraine
Head of The Ukrainian National Drug and Alcohol Observatory,Kyiv,Ukraine
Head of Kyiv affiliation of the Department of Narcology, Professor, The Post-graduate
Medical Academy, Kharkiv, Ukraine
Vice Director of The City Narcological Hospital, Kyiv, Ukraine
Awards, Honors and Membership in Honorary Societies:
- Membership in The National Coordinative Board in Drug and Alcohol issues, Cabinet
of Ministers of Ukraine, Kyiv-
-The membership in Kettil Bruun Society for Alcohol Studies, Helsinki, Finland
- Chairman, All-Ukrainian Narcological Association, Kyiv, Ukraine
- 2005 The Honored Doctor of Ukraine National Award
[Back || Top]
Donnie W. Watson, Ph.D.
University of California, Los Angeles-Integrated
Substance Abuse Programs/USA
Psychologist & Investigator – UCLA ISAP
Dr. Watson, who is trained as a clinical and research psychologist, has over
20 years of experience in substance prevention and treatment research. Over the
past 5 years, he has broadened his area of research to include HIV prevention
research with at risk adolescents. Dr. Watson has been an integral part of a
number of funded grants working with adolescent and adult substance abuse and
HIV risk populations. He is published and has presented nationally and internationally
on substance abuse and HIV related issues. He is a Core Faculty Member of UCLA’s
Integrated Substance Abuse Programs; Core Scientist with the UCLA’s Comprehensive
HIV Prevention and Treatment Services; Social Scientist for the American
Psychological Association's (APA's) Office on AIDS Capacity Building Assistance
(CBA) Behavioral and Social Scientist Volunteer Training for Preventing HIV Among
African Americans in the Western Region; Core Scientist with the UCLA’s
AIDS Institute in the program areas of sociocultural prevention and AIDS in Africa;
and Principal Investigator with Friends Research Institute, Inc.
[Back || Top]
Constance Weisner, DrPH, MSW
University of California, San Francisco/USA
Professor, Department of Psychiatry, University of California, San Francisco
Investigator, Division of Research, Northern California Kaiser Permanente.
Professor Constance Weisner has a doctorate in Public Health from the University
of California, Berkeley. She directs a research program addressing access, outcome,
and cost of alcohol and drug treatment, including studies in health and social
service systems. She is a member of the International Expert Advisory Group on
Alcohol and Drug Dependence of the World Health Organization and of the National
Advisory Council of the National Institute on Drug Abuse. She has participated
on several Institute of Medicine committees, including “Broadening
the Base of Alcohol Treatment” and the new “Adapting ‘Crossing
the Quality Chasm’ to Mental Health and Addictive Disorders.” She
is the Principal Investigator of NIAAA, NIDA, and RWJF research grants. Her on-going
work on the changing systems for receiving health, substance abuse and mental
health services.
[Back || Top]
Stan Weisner, Ph.D., MSW
University of California, Berkeley/USA
Department Chair for Behavioral and Biological Sciences at UC Berkeley Extension.
Dr. Stan Weisner administers a Certificate Program in Alcohol and Drug Studies
and also develops and oversees continuing education programs for public health,
social service and mental health professionals. He taught at the
graduate and undergraduate level for several years at the School of Social Welfare
at UC Berkeley. Stan has worked internationally in several teaching and
research roles. He is the author of Social Work in Kenya: Training and
Perfomance (KIA, 1972), “Community Work: Evaluation in the Health Sector” in Reaching
People --- The Structure of Neighborhood Services (Sage, 1977), Information
is Empowering: Developing Public Library Services for Youth at Risk (California
State Library, 1992), and “Applying a Transfer of Learning Model to Continuing
Education”, Continuing Higher Education Review, (Harvard University,
2005). Most recently, he has completed several consultancies in Beijing,
China with UNICEF on children, youth, and family services.
[Back || Top]
* The biographical information we received often needed to be
edited to achieve comparable length per attendee. Any omissions,
grammatical errors, or stylistic oddities in each paragraph
should be attributed to the editor rather than to the attendee!
|
September 5-7, 2005